Edition:
United States

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

6.49USD
23 Sep 2016
Change (% chg)

-- (+0.00%)
Prev Close
$6.49
Open
$6.48
Day's High
$6.56
Day's Low
$6.36
Volume
96,454
Avg. Vol
127,424
52-wk High
$6.60
52-wk Low
$3.24

CORT.OQ

Chart for CORT.OQ

About

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company's focus is on those disorders that are associated with a steroid hormone cortisol. Elevated levels and abnormal release... (more)

Overall

Beta: 1.44
Market Cap(Mil.): $717.76
Shares Outstanding(Mil.): 110.59
Dividend: --
Yield (%): --

Financials

  CORT.OQ Industry Sector
P/E (TTM): 562.39 36.61 36.60
EPS (TTM): 0.01 -- --
ROI: 4.36 14.46 13.91
ROE: 7.08 15.26 14.82

BRIEF-Corcept Therapeutics provides update on cortisol modulation oncology program

* Corcept Therapeutics provides update of progress in cortisol modulation oncology program Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Jun 02 2016

BRIEF-Corcept Therapeutics Q1 non-GAAP earnings per share $0.02

* Corcept Therapeutics announces first quarter 2016 financial results and provides corporate update

May 03 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : S&P Capital IQ Quantitative Report
$104.00
Provider : Pechala's Reports
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.